Clinical Trial Update: Study Evaluating Rapamune in Patients After Kidney Transplantation

View source ↗

Summary

The clinical trial evaluating Rapamune (sirolimus) in kidney transplant recipients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplantation

Drugs mentioned

• Rapamune (sirolimus)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Renal Transplantation | Status: TERMINATED